OnKure Therapeutics, Inc.
OKUR
$4.25
-$0.15-3.41%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 14.77% | -5.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.55% | -8.88% | |||
| Operating Income | -10.55% | 8.88% | |||
| Income Before Tax | -12.25% | 8.14% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.25% | 8.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.25% | 8.14% | |||
| EBIT | -10.55% | 8.88% | |||
| EBITDA | -10.63% | 8.91% | |||
| EPS Basic | -11.61% | 8.58% | |||
| Normalized Basic EPS | -11.62% | 8.59% | |||
| EPS Diluted | -11.61% | 8.58% | |||
| Normalized Diluted EPS | -11.62% | 8.59% | |||
| Average Basic Shares Outstanding | 0.57% | 0.49% | |||
| Average Diluted Shares Outstanding | 0.57% | 0.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||